Idexx Laboratories (IDXX)
NASDAQ:IDXX
Holding IDXX?
Track your performance easily

Idexx Laboratories (IDXX) Financial Statements

1,925 Followers

Idexx Laboratories Financial Overview

Idexx Laboratories's market cap is currently ―. The company's EPS TTM is $10.088; its P/E ratio is 50.68; Idexx Laboratories is scheduled to report earnings on October 29, 2024, and the estimated EPS forecast is $2.68. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.00B$ 964.10M$ 901.60M$ 915.53M$ 943.63M
Gross Profit$ 619.16M$ 593.07M$ 526.17M$ 737.00M$ 943.63M
EBIT$ 259.06M$ 303.39M-$ 276.54M$ 296.47M
EBITDA$ 291.25M$ 333.29M-$ 305.52M$ 324.33M
Net Income Common Stockholders$ 211.40M$ 235.58M$ 194.52M$ 212.23M$ 224.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 401.59M$ 397.43M$ 453.93M$ 331.70M$ 132.84M
Total Assets$ 3.41B$ 3.35B$ 3.26B$ 3.09B$ 2.87B
Total Debt$ 1.05B$ 1.05B$ 1.05B$ 1.12B$ 1.13B
Net Debt$ 646.23M$ 652.22M$ 593.62M$ 788.58M$ 1.00B
Total Liabilities$ 1.83B$ 1.78B$ 1.78B$ 1.79B$ 1.78B
Stockholders Equity$ 1.58B$ 1.57B$ 1.48B$ 1.30B$ 1.09B
Cash Flow-
Free Cash Flow$ 215.01M$ 168.31M-$ 238.34M$ 172.84M
Operating Cash Flow$ 248.31M$ 198.59M$ 249.85M$ 272.43M$ 200.31M
Investing Cash Flow$ -32.91M$ -106.94M$ -30.43M$ -27.84M$ -27.47M
Financing Cash Flow$ -210.24M$ -144.07M$ -101.84M$ -43.04M$ -151.03M
Currency in USD

Idexx Laboratories Earnings and Revenue History

Idexx Laboratories Debt to Assets

Idexx Laboratories Cash Flow

Idexx Laboratories Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis